MetaCap

Decoy Therapeutics (DCOY) vs Genprex (GNPX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Decoy Therapeutics is the larger company by market cap ($2.0 million vs $1.9 million), about 1.0 times the size. On valuation, Genprex trades at a lower trailing P/E (0.0x vs 0.0x for Decoy Therapeutics).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DCOY-48.48%GNPX-44.66%
+8%-22%-51%
Oct 7, 20261 yearNov 20, 2026
DCOY-43.58%GNPX-46.69%
+2%-23%-49%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DCOY versus GNPX key metrics
MetricDCOYGNPX
Share price$0.8294$1.45
Market cap$1.98M$1.94M
1-day change-4.68%-13.17%
P/E ratio (TTM)0.030.01
EPS (TTM)$31.19$98.47
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-12.52M$-16.23M
52-week high$16.92$80.96
52-week low$0.80$1.45
Distance from 52-week high-95.10%-98.21%
Analyst consensusstrong_buy—
Avg. price target upside+261.71%—
Average volume2.17M168.88K
Shares outstanding2.39M1.33M
Employees1113
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Decoy Therapeutics trades at a higher earnings multiple (0.0x vs 0.0x trailing P/E).

About Decoy Therapeutics

DCOY stock →

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company.

Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees

About Genprex

GNPX stock →

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.

Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees

DCOY vs GNPX FAQ

Which is bigger, Decoy Therapeutics or Genprex?

Decoy Therapeutics (DCOY) is larger, with a market capitalization of $1.98M compared with $1.94M for Genprex (GNPX).

Which has the lower P/E ratio, DCOY or GNPX?

GNPX has the lower trailing P/E at 0.0, versus 0.0 for DCOY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Decoy Therapeutics and Genprex in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons